Compounds > sesamin
Page last updated: 2024-08-25

sesamin and Angiogenesis, Pathologic

sesamin has been researched along with Angiogenesis, Pathologic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, Y; Huang, Y; Jiang, M; Li, J; Li, L; Liu, Z; Tang, Y; Zhou, L1
Aggarwal, BB; Guha, S; Harikumar, KB; Joy, B; Krishnan, S; Pandey, MK; Sung, B; Tharakan, ST1
Chang, CC; Huang, TS; Lee, CC; Lin, SJ; Liu, KJ; Wu, YC1

Other Studies

3 other study(ies) available for sesamin and Angiogenesis, Pathologic

ArticleYear
Sesamin inhibits hypoxia-stimulated angiogenesis
    Food & function, 2022, Aug-30, Volume: 13, Issue:17

    Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Dioxoles; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lignans; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Vascular Endothelial Growth Factor A

2022
Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
    Molecular cancer research : MCR, 2010, Volume: 8, Issue:5

    Topics: Angiogenic Proteins; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxoles; Growth Inhibitors; Humans; Lignans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Sesame Oil; Signal Transduction

2010
Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
    Inflammation, 2011, Volume: 34, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Culture Media, Conditioned; Dioxoles; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-6; Interleukin-8; Lignans; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; RNA, Neoplasm; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2011